Cargando…

Analysis of Iron Metabolism in Chronic Chagasic Cardiomyopathy

Changes in iron metabolism in heart failure (HF) have been described as an important prognostic marker. To check if the markers of iron kinetics are related to the morbidity and etiology of chagasic cardiomyopathy. Patients with Chronic Chagasic Cardiomyopathy (CCC, n = 40), with indeterminate form...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miranda, Carla Paixão, Botoni, Fernando Antônio, Nunes, Maria do Carmo Pereira, Rocha, Manoel Otávio da Costa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2019
Materias:	Brief Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371820/ https://www.ncbi.nlm.nih.gov/pubmed/30785584 http://dx.doi.org/10.5935/abc.20190006

Ejemplares similares

The metabogenic role of iron in chronic chagasic cardiac failure
por: Miranda, Carla Paixão, et al.
Publicado: (2015)

Immunopharmacological Approach of Carvedilol in Chronic Chagas Heart Disease
por: Miranda, Carla Paixão, et al.
Publicado: (2014)

Níveis Séricos do BDNF na Proteção Cardiovascular e em Resposta ao Exercício
por: Miranda, Carla Paixão, et al.
Publicado: (2021)

Biomakers in Chronic Chagas Cardiomyopathy
por: Rodrigues, Angela Braga, et al.
Publicado: (2022)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies
por: da Matta, José Alberto Martins, et al.
Publicado: (2012)

Chagasic cardiomyopathy is marked by a unique signature of activated CD4(+) T cells
por: Almeida, Gregório Guilherme, et al.
Publicado: (2022)

Uso de Estatinas Melhora a Proteção Cardiometabólica Promovida pelo Treinamento Físico em Ambiente Aquático: Um Estudo Clínico Randomizado
por: Miranda, Carla Paixão, et al.
Publicado: (2022)

Diminished Prolinemia in Chronic Chagasic Patients: A New Clue for Disease Pathology?
por: Rocha, Sandra Carla, et al.
Publicado: (2019)

Left Atrial Function in Patients with Chronic Chagasic Cardiomyopathy
por: Fragata, Claudia da Silva, et al.
Publicado: (2015)

Innate immune receptors over expression correlate with chronic chagasic cardiomyopathy and digestive damage in patients
por: Pereira, Nathalie de Sena, et al.
Publicado: (2018)

Vasoactive intestinal peptide degradation might influence Interleukin-17 expression in cardiac chagasic patients
por: Pereira, Francielle Beltrão, et al.
Publicado: (2018)

Intestinal permeability evaluation in patients with chronic Chagas heart failure
por: Rodrigues, Angela Braga, et al.
Publicado: (2023)

Current and emerging therapeutic options for the treatment of chronic chagasic cardiomyopathy
por: Muratore, Claudio A, et al.
Publicado: (2010)

Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
por: Brasil, Guilherme Visconde, et al.
Publicado: (2020)

Chagas Cardiomyopathy Manifestations and Trypanosoma cruzi Genotypes Circulating in Chronic Chagasic Patients
por: Ramírez, Juan David, et al.
Publicado: (2010)

Clinical and Echocardiographic Predictors of Mortality in Chagasic Cardiomyopathy - Systematic Review
por: Pereira, Clodoval de Barros, et al.
Publicado: (2014)

A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial
por: Holanda, Marcelo Teixeira, et al.
Publicado: (2018)

Stem Cell-Based Therapies in Chagasic Cardiomyopathy
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2015)

Chemotherapeutic Efficacy of Phosphodiesterase Inhibitors in Chagasic Cardiomyopathy
por: Wen, Jian-jun, et al.
Publicado: (2016)

Prognostic Factors in Severe Chagasic Heart Failure
por: Costa, Sandra de Araújo, et al.
Publicado: (2017)

Cardiovascular Magnetic Resonance Imaging Evidence of Edema in Chronic Chagasic Cardiomyopathy
por: Diaz, Andrés, et al.
Publicado: (2019)

Chagasic Cardiomyopathy in Immigrants from Latin America to Spain
por: Pérez de Ayala, Ana, et al.
Publicado: (2009)

Evaluation of VDR gene polymorphisms in Trypanosoma cruzi infection and chronic Chagasic cardiomyopathy
por: Leon Rodriguez, Daniel A, et al.
Publicado: (2016)

Pentoxifylline Reverses Chronic Experimental Chagasic Cardiomyopathy in Association with Repositioning of Abnormal CD8(+) T-Cell Response
por: Pereira, Isabela Resende, et al.
Publicado: (2015)

Association Between Trypanosoma cruzi DNA in Peripheral Blood and Chronic Chagasic Cardiomyopathy: A Systematic Review
por: Bosch-Nicolau, Pau, et al.
Publicado: (2022)

Echocardiographic Measurements in a Preclinical Model of Chronic Chagasic Cardiomyopathy in Dogs: Validation and Reproducibility
por: Carvalho, Eduardo B., et al.
Publicado: (2019)

Signal Transducer and Activator of Transcription-3 Modulation of Cardiac Pathology in Chronic Chagasic Cardiomyopathy
por: Hoffman, Kristyn A., et al.
Publicado: (2021)

Murine heart gene expression during acute Chagasic myocarditis
por: Henao-Martínez, Andrés F., et al.
Publicado: (2015)

Biomarkers and Their Possible Functions in the Intestinal Microenvironment of Chagasic Megacolon: An Overview of the (Neuro)inflammatory Process
por: do Carmo Neto, José Rodrigues, et al.
Publicado: (2021)

Functional antibodies against G-protein coupled receptors in Beagle dogs infected with two different strains of Trypanosoma cruzi
por: Wallukat, Gerd, et al.
Publicado: (2022)

CD14 genotype and functional dichotomy of CD14+ and CD14- cells are associated with activated immune response and development of Chagas dilated cardiomyopathy
por: Costa, Germano Carneiro, et al.
Publicado: (2020)

Trypanosoma cruzi P21: a potential novel target for chagasic cardiomyopathy therapy
por: Teixeira, Thaise Lara, et al.
Publicado: (2015)

Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas’ Heart Disease: Antagonistic Participation of CCR1(+) and CCR5(+) Cells in Chronic Chagasic Cardiomyopathy
por: Batista, Angelica Martins, et al.
Publicado: (2018)

Prognostic value of serum brain-derived neurotrophic factor levels in patients with Chagas cardiomyopathy
por: Costa, Henrique S, et al.
Publicado: (2018)

Translating Chagasic dilating cardiomyopathy to surgical therapies: An under published global challenge
por: Groom, Zoe C, et al.
Publicado: (2019)

Improved Biomarker and Imaging Analysis for Characterizing Progressive Cardiac Fibrosis in a Mouse Model of Chronic Chagasic Cardiomyopathy
por: Hoffman, Kristyn A., et al.
Publicado: (2019)

Chagasic infection among blood donors in Brazil: an integrative review
por: Cardoso, Darwin Renne Florencio, et al.
Publicado: (2018)

Electrophysiological study in chagasics with syncope and conduction disorder
por: Dreicon, Alexia Hallack, et al.
Publicado: (2023)

Galectin-3 and fibrosis intensity in Chronic Chagas Cardiomyopathy: a systematic review
por: Chaves, Ana Thereza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9qsrpfm9pbjrh86cn70al9p83u